- Home
- Publications
- Publication Search
- Publication Details
Title
Chronic administration of theobromine inhibits mTOR signal in rats
Authors
Keywords
-
Journal
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2018-11-19
DOI
10.1111/bcpt.13175
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Basic & Clinical Pharmacology & Toxicology Policy for Experimental and Clinical studies
- (2018) Pernille Tveden-Nyborg et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- Chocolate intake and risk of clinically apparent atrial fibrillation: the Danish Diet, Cancer, and Health Study
- (2017) Elizabeth Mostofsky et al. HEART
- Theobromine up-regulates cerebral brain-derived neurotrophic factor and facilitates motor learning in mice
- (2017) Mitsugu Yoneda et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Chocolate intake is associated with better cognitive function: The Maine-Syracuse Longitudinal Study
- (2016) Georgina E. Crichton et al. APPETITE
- Protein kinase A and Epac activation by cAMP regulates the expression of glial fibrillary acidic protein in glial cells
- (2016) Naotoshi Sugimoto et al. Archives of Biological Sciences
- mTOR activation is a biomarker and a central pathway to autoimmune disorders, cancer, obesity, and aging
- (2015) Andras Perl Annals of the New York Academy of Sciences
- mTOR in Brain Physiology and Pathologies
- (2015) Joël Bockaert et al. PHYSIOLOGICAL REVIEWS
- Global and local missions of cAMP signaling in neural plasticity, learning, and memory
- (2015) Daewoo Lee Frontiers in Pharmacology
- Theobromine, the Primary Methylxanthine Found inTheobroma cacao, Prevents Malignant Glioblastoma Proliferation by Negatively Regulating Phosphodiesterase-4, Extracellular Signal-regulated Kinase, Akt/mammalian Target of Rapamycin Kinase, and Nuclear Factor-Kappa B
- (2014) Naotoshi Sugimoto et al. NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL
- Targeting the mTOR Signaling Network for Alzheimer’s Disease Therapy
- (2013) Chong Wang et al. MOLECULAR NEUROBIOLOGY
- Role of mTOR Signaling in Tumor Cell Motility, Invasion and Metastasis
- (2012) Shile Huang et al. CURRENT PROTEIN & PEPTIDE SCIENCE
- Mammalian target of rapamycin: A valid therapeutic target through the autophagy pathway for alzheimer's disease?
- (2012) Zhiyou Cai et al. JOURNAL OF NEUROSCIENCE RESEARCH
- Chronic Activation of mTOR Complex 1 Is Sufficient to Cause Hepatocellular Carcinoma in Mice
- (2012) S. Menon et al. Science Signaling
- The molecular biology of memory: cAMP, PKA, CRE, CREB-1, CREB-2, and CPEB
- (2012) Eric R Kandel Molecular Brain
- mTOR as a multifunctional therapeutic target in HIV infection
- (2011) Ferdinando Nicoletti et al. DRUG DISCOVERY TODAY
- Activation of tumor suppressor protein PTEN and induction of apoptosis are involved in cAMP-mediated inhibition of cell number in B92 glial cells
- (2011) Naotoshi Sugimoto et al. NEUROSCIENCE LETTERS
- Inhibition of mTOR by Rapamycin Abolishes Cognitive Deficits and Reduces Amyloid-β Levels in a Mouse Model of Alzheimer's Disease
- (2010) Patricia Spilman et al. PLoS One
- Treatment with rapamycin ameliorates clinical and histological signs of protracted relapsing experimental allergic encephalomyelitis in Dark Agouti rats and induces expansion of peripheral CD4+CD25+Foxp3+ regulatory T cells
- (2009) Marco Donia et al. JOURNAL OF AUTOIMMUNITY
- Reversal of learning deficits in a Tsc2 +/− mouse model of tuberous sclerosis
- (2008) Dan Ehninger et al. NATURE MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More